Impact of Postoperative Pyuria on Treatment Outcomes After PVP

Does Postoperative Pyuria Influence Treatment Outcomes After Photoselective Vaporization of the Prostate (PVP)?: A Short-term Serial Follow-up Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02241902

Enrollment

120

Registered

2014-09-16

Start date

2014-08-31

Completion date

Unknown

Last updated

2014-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Hyperplasia, Pyuria

Brief summary

The aim of this study was to identify serial changes in the incidence of postoperative pyuria after the Photoselective Vaporization of the Prostate (PVP), to determine whether the presence of postoperative pyuria could be correlated with surgical outcomes after surgery and to identify predicting factors that influence on persistent pyuria after the PVP.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

40 Years to 90 Years

Healthy volunteers

Inclusion criteria

* men who underwent photoselective vaporization (PVP) using 80 watt potassium-titanyl-phosphate (KTP) laser or 120 watt high-power-system (HPS) laser for benign prostatic hyperplasia refractory to medical treatment * sterile urine on urinalysis and urine culture before surgery * absence of indwelling urethral catheter before surgery

Exclusion criteria

* previous diagnosis of prostate carcinoma or bladder cancer * co-existence of urinary stone * any antibiotic treatment within 2-weeks before surgery

Design outcomes

Primary

Measure	Time frame
Change in the subtotal storage symptoms score of the International Prostate Symptom Score (IPSS)	1-week, and 1-, 3- and 6-months after the surgery

Countries

South Korea

Contacts

Primary ContactMin Chul Cho, M.D., Ph.D.

cmc1206@empal.com82-31-961-7456

Outcome results